Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Life Sciences|January 24, 1983
Dopaminergic supersensitivity at distant sites following induced epileptic fociJ G Csernansky, C A Holman, K A Bonnet, et al.
The Journal of Nervous and Mental Disease|February 1, 1987
Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neurolepticsE S Prosser, J G Csernansky, J Kaplan, et al.
Psychiatry Research|September 1, 1990
Growth hormone response to growth hormone releasing hormone in depression and schizophreniaC A Peabody, M D Warner, E Markoff, et al.
Biological Psychiatry|August 1, 1994
ERPs in schizophrenia: effects of antipsychotic medicationJ M Ford, P M White, J G Csernansky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1996
The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatientsA L Hoff, W O Faustman, M Wieneke, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1994
Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoriaJ W Newcomer, L S Miller, W O Faustman, et al.
Neuroreport|February 15, 1995
3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neuronsM I Behrens, J Koh, L M Canzoniero, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 11, 1990
5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristicsJ G Csernansky, R J King, W O Faustman, et al.
Pageof 13